Commerce Bank Charles River Laboratories International, Inc. Transaction History

Commerce Bank

$16.7 Billion
Q2 2025

A detailed history of Commerce Bank transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Commerce Bank holds 5,166 shares of CRL stock, worth $923,990. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,166

Previous 5,226 1.15%

Holding current value

$923,990

Previous $786,000 0.38%

% of portfolio

0.0%

Previous 0.01%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	SELL	$99.75 - $151.89 $5,985 - $9,113	-60 Reduced 1.15%	5,166 $783,000
Q1 2025 May 08, 2025	SELL	$150.52 - $190.14 $5,719 - $7,225	-38 Reduced 0.72%	5,226 $786,000
Q4 2024 Feb 13, 2025	SELL	$178.58 - $220.69 $23,751 - $29,351	-133 Reduced 2.46%	5,264 $971,000
Q3 2024 Nov 08, 2024	SELL	$187.96 - $245.29 $20,111 - $26,246	-107 Reduced 1.94%	5,397 $1.06 Million
Q2 2024 Aug 12, 2024	SELL	$206.39 - $268.73 $29,100 - $37,890	-141 Reduced 2.5%	5,504 $1.14 Million
Q1 2024 May 03, 2024	SELL	$203.52 - $273.43 $43,960 - $59,060	-216 Reduced 3.69%	5,645 $1.53 Million
Q4 2023 Feb 09, 2024	SELL	$164.52 - $238.84 $12,832 - $18,629	-78 Reduced 1.31%	5,861 $1.39 Million
Q3 2023 Nov 13, 2023	BUY	$194.44 - $217.61 $26,249 - $29,377	135 Added 2.33%	5,939 $1.16 Million
Q2 2023 Aug 08, 2023	SELL	$183.71 - $210.25 $8,083 - $9,251	-44 Reduced 0.75%	5,804 $1.22 Million
Q1 2023 May 04, 2023	BUY	$191.89 - $259.92 $28,015 - $37,948	146 Added 2.56%	5,848 $1.18 Million
Q4 2022 Feb 10, 2023	SELL	$197.11 - $250.07 $985 - $1,250	-5 Reduced 0.09%	5,702 $1.24 Million
Q3 2022 Nov 04, 2022	SELL	$182.44 - $250.54 $76,807 - $105,477	-421 Reduced 6.87%	5,707 $1.12 Million
Q2 2022 Aug 12, 2022	BUY	$204.13 - $302.4 $123,294 - $182,649	604 Added 10.93%	6,128 $1.31 Million
Q1 2022 May 09, 2022	SELL	$255.51 - $362.11 $201,597 - $285,704	-789 Reduced 12.5%	5,524 $1.57 Million
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $125,091 - $159,730	-356 Reduced 5.34%	6,313 $2.38 Million
Q3 2021 Nov 09, 2021	SELL	$372.64 - $458.3 $44,344 - $54,537	-119 Reduced 1.75%	6,669 $2.75 Million
Q2 2021 Aug 09, 2021	BUY	$294.17 - $371.65 $25,004 - $31,590	85 Added 1.27%	6,788 $2.51 Million
Q1 2021 May 05, 2021	SELL	$249.67 - $299.48 $114,848 - $137,760	-460 Reduced 6.42%	6,703 $1.94 Million
Q4 2020 Feb 09, 2021	SELL	$222.0 - $252.62 $13,320 - $15,157	-60 Reduced 0.83%	7,163 $1.79 Million
Q3 2020 Nov 06, 2020	BUY	$175.56 - $226.45 $1,580 - $2,038	9 Added 0.12%	7,223 $1.64 Million
Q2 2020 Aug 07, 2020	SELL	$118.84 - $189.72 $237 - $379	-2 Reduced 0.03%	7,214 $1.26 Million
Q1 2020 May 08, 2020	BUY	$98.9 - $178.34 $9,494 - $17,120	96 Added 1.35%	7,216 $911,000
Q4 2019 Feb 14, 2020	SELL	$126.05 - $152.76 $58,613 - $71,033	-465 Reduced 6.13%	7,120 $1.09 Million
Q3 2019 Nov 12, 2019	BUY	$125.07 - $143.67 $8,879 - $10,200	71 Added 0.94%	7,585 $1 Million
Q2 2019 Aug 07, 2019	SELL	$123.4 - $148.55 $146,475 - $176,328	-1,187 Reduced 13.64%	7,514 $1.07 Million
Q1 2019 May 08, 2019	SELL	$104.82 - $146.73 $11,530 - $16,140	-110 Reduced 1.25%	8,701 $1.26 Million
Q4 2018 Feb 11, 2019	SELL	$105.09 - $137.23 $128,314 - $167,557	-1,221 Reduced 12.17%	8,811 $997,000
Q3 2018 Nov 02, 2018	SELL	$112.11 - $134.54 $974,235 - $1.17 Million	-8,690 Reduced 46.42%	10,032 $1.35 Million
Q2 2018 Aug 08, 2018	SELL	$102.37 - $117.25 $78,005 - $89,344	-762 Reduced 3.91%	18,722 $2.1 Million
Q1 2018 May 03, 2018	BUY	$98.19 - $115.2 $388,832 - $456,192	3,960 Added 25.51%	19,484 $2.08 Million
Q4 2017 Feb 12, 2018	BUY	$100.43 - $118.09 $900,455 - $1.06 Million	8,966 Added 136.72%	15,524 $1.7 Million
Q3 2017 Nov 07, 2017	BUY	$96.72 - $109.26 $634,289 - $716,527	6,558	6,558 $709,000

Others Institutions Holding CRL

# of Institutions

637

Shares Held

52.8M

Call Options Held

1.42M

Put Options Held

1.42M

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.

Account